Hedge Fund - Enavate Sciences
Get Email AlertsJames Boylan Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Enavate Sciences |
| Manager | James Boylan |
| Portfolio Value | $139,236,883 |
| Change This QTR | +99.00% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | Upstream Bio Inc | 2,459,703 | $40,437,517 | NEW | 29.04% | ||
| 2. | IMNM | 3,478,261 | $36,939,132 | NEW | 26.52% | ||
| 3. | Zenas Biopharma Inc | 3,761,359 | $30,805,530 | NEW | 22.12% | ||
| 4. | Camp4 Therapeutics Corp | 3,785,802 | $19,761,886 | NEW | 14.19% | ||
| 5. | CMPX | 7,788,150 | $11,292,818 | NEW | 8.11% |
